Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography

Journal of the American College of Cardiology

Volumn 28, Issue 4, 1996, Pages 948-958

  Vom Dahl, Juergen ^a   Altehoefer, Carsten ^a   Sheehan, Florence H ^b   Buechin, Petra ^a   Uebis, Rainer ^a   Messmer, Bruno J ^a   Buell, Udalrich ^a   Hanrath, Peter ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

EID: 0030273421     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00259-8     Document Type: Article

References (58)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
2. Bolli R. Myocardial "stunning" in man. Circulation 1992;86:1671-91.
3. Braunwald E, Rutherford EJD. Reversible ischemic left ventricular dysfunction: evidence for the hibernating myocardium. J Am Coll Cardiol 1986;8:1467-70.
4. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
5. Rees G, Bristow JD, Kremkau EL, et al. Influence of aortocoronary bypass surgery on left ventricular performance. N Engl J Med 1971;284:1116-20.
6. Chatterjee K, Swan HJC, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patients with coronary heart disease with and without previous myocardial infarction. Circulation 1973;67:276-86.
7. Flameng W, Suy R, Schwarz F, et al. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy postrevascularization surgery. Am Heart J 1981;102:846-57.
8. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function. Circulation 1983;68:785-95.
9. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction (CASS). N Engl J Med 1985;312:1665-71.
10. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized coronary artery surgery study (CASS). Circulation 1990;82:1629-46.
11. Bell MR, Gersh BJ, Schaff HV, et al. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: a report from the Coronary Artery Surgery Study (CASS) registry. Circulation 1992;86:446-57.
12. Mickleborough LL, Maruyama H, Takagi Y, Mohamed S, Sun Z, Ebisuzaki L. Results of revascularization in patients with severe left ventricular dysfunction. Circulation 1995;92 Suppl II:II-73-9.
13. Cohen M, Charney R, Hershman R, Fuster V, Gorlin R, Francis X. Reversal of chronic ischemic myocardial dysfunction after transluminal coronary angioplasty. J Am Coll Cardiol 1988;12:1193-8.
14. van den Berg EKJ, Popma JJ, et al. Reversible segmental left ventricular dysfunction after coronary angioplasty. Circulation 1990;81:1210-6.
15. vom Dahl J, Uebis R, Sheehan FH, et al. Factors influencing outcome of regional wall motion following percutaneous transluminal coronary angioplasty. Coronary Artery Dis 1992;3:489-98.
16. Schwaiger M, Brunken R, Grover-McKay M, et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 1986;8:800-8.
17. Brunken R, Tillisch J, Schwaiger M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986;73:951-63.
18. Schelbert HR, Buxton D Insights into coronary artery disease gained from metabolic imaging. Circulation. 78:1988;496-505.
19. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis 1989;32:217-38.
20. Schwaiger M, Hicks RJ. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991;32:565-78.
21. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
22. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-5.
23. Nienaber CA, Brunken RC, Sherman CD, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991;18:966-78.
24. Carrel T, Jenni R, Haubold-Reuter S, von Schulthess G, Pasic M, Turina M. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardio-thorac Surg 1992;6:479-84.
25. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992;20:569-77.
26. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. Circulation 1992;85:1347-53.
27. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22:1587-97.
28. Knuuti MJ, Saraste M, Nuutila P, et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 1994;127:785-96.
29. vom Dahl J, Eitzman DT, Al-Aouar ZR, Kanter HL, Hicks RJ, Schwaiger M. Relationship between regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2355-66.
30. Altehoefer C, Kaiser H-J, Doerr R, et al. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in Tc-99m MIBI SPECT: a comparative study in patients with coronary artery disease. Eur J Nucl Med 1992;19:334-42.
31. Altehoefer C, vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994;35:569-74.
32. Dodge HT, Sandler H, Baxley WA, Hawley RR Usefulness and limitations of radiographic methods for determining left ventricular volumes. Am J Cardiol. 18:1966;10-24.
33. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J, Woo HW Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation. 74:1986;293-305.
34. Sheehan FH, Schofer J, Mathey DGet al. Measurement of regional wall motion from biplane contrast ventriculograms: a comparison of the 30 degree right anterior oblique and 60 degree left anterior oblique projections in patients with acute myocardial infarctions. Circulation. 74:1986;796-804.
35. Sheehan FH, Mathey DG, Schofer J, Krebber H-J, Dodge HT. Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase. Am J Cardiol 1983;52:431-8.
36. Jeppson GM, Clayton PD, Blair TJ, Liddle HV, Jensen RL, Klausner SC. Changes in left ventricular wall motion after coronary bypass surgery: signal or noise? Circulation 1981;64:945-51.
37. Sheehan FH, Stewart DK, Dodge HT, Mitten S, Bolson EL, Brown BG. Variability in the measurement of regional left ventricular wall motion from contrast angiograms. Circulation 1983;68:550-9.
38. Vignola P, Boucher C, Curfman G Abnormal interventricular septal motion following cardiac surgery: clinical, surgical, echocardiographic and radionuclide correlates. Am Heart J. 97:1979;27-34.
39. Okada RD, Murphy JH, Boucher CA, et al. Relationship between septal perfusion, viability, and motion before and after coronary artery bypass surgery. Am Heart J 1992;124:1190-5.
40. Stirner H, Buell U, Kleinhans E. Three-dimensional ROI-based quantification of stress/rest 201-T1 myocardial SPECT: presentation of a method. Nuklearmedizin 1986;25:128-33.
41. Altehoefer C, vom Dahl J, Buell U, Uebis R, Kleinhans E, Hanrath P Comparison of thallium-201 SPECT after rest injection and F-18 FDG positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease. Eur J Nucl Med. 21:1994;37-45.
42. Vanoverschelde J-LJ, Wijns W, Depre C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993;87:1513-23.
43. vom Dahl J, Altehoefer C, Schulz G, Buechin P, Beilin I, Buell Uet al. Long-term prognosis in patients undergoing nuclear imaging for evaluation of viability by MIBI SPECT and FDG PET [abstract]. J Nucl Cardiol. 2:1995;46.
44. Melgares R, Prieto JA, Azpitarte J. Significant coronary restenosis limits the recovery of regional left ventricular myocardial dysfunction achieved after successful coronary angioplasty. Eur Heart J 1993;14:866-75.
45. Miketic S, Carlsson J, Tebbe U. Improvement of global and regional left ventricular function by percutaneous transluminal coronary angioplasty after myocardial infarction. J Am Coll Cardiol 1995;25:843-7.
46. Gibson RS, Watson DD, Taylor GJ, et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983;1:804-15.
47. Ragosta M, Beller GA, Watson D, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201-thallium imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely reduced left ventricular function. Circulation 1993;87:1630-41.
48. Udelson JE, Coleman PS, Metherall J, et al. Predicting recovery of severe regional ventricular dysfunction: comparison resting scintigraphy with Tl-201 and Tc-99m-sestamibi. Circulation 1994;89:2552-61.
49. Sawada SG, Allman KC, Muzik O, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994;23:92-8.
50. Dilsizian V, Arrighi JA, Diodati JG, et al. Myocardial viability in patients with chronic coronary artery disease: comparison of Tc-99m-sestamibi with thallium reinjection and F-18 fluorodeoxyglucose. Circulation 1994;89:578-87.
51. Schneider CA, Voth E, Theissen P, et al. Assessment of myocardial viability in patients with chronic myocardial infarction by F-18-fluoro-D-glucose positron emission tomography and Tc-99m-MIBI-SPECT. Z Kardiol 1994;83:124-31.
52. Soufer R, Dey HM, Ng CK, Zaret BL. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability. Am J Cardiol 1995;75:1214-9.
53. Buell U, Fouroutan Y, Hellwig D, et al. Comparison of relative F-18 FDG uptake to metabolic rate (MRGlucose) in the myocardium in coronary artery disease classified by Tc-99m MIBI. Nuklearmedizin 1995;34:223-8.
54. Eitzman D, Al-Aouar ZR, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
55. Tamaki N, Kawamoto M, Takahashi N, et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 1993;22:1621-7.
56. DiCarli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
57. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction: relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
58. Lucignani G, Paolini G, Landoni C, et al. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease. Eur J Nucl Med 1992;19:874-81.